Smyth MJ - Search Results

1

NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.

Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J, Möller A, Smyth MJ. Chow MT, et al. Among authors: smyth mj. Cancer Res. 2012 Nov 15;72(22):5721-32. doi: 10.1158/0008-5472.CAN-12-0509. Epub 2012 Sep 17. Cancer Res. 2012. PMID: 22986739

2

Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.

Smyth MJ, Bogdanovski M, McKenzie IF, Pietersz GA. Smyth MJ, et al. Cancer Res. 1991 Jan 1;51(1):310-7. Cancer Res. 1991. PMID: 1988093

3

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Smyth MJ, Crowe NY, Godfrey DI. Smyth MJ, et al. Int Immunol. 2001 Apr;13(4):459-63. doi: 10.1093/intimm/13.4.459. Int Immunol. 2001. PMID: 11282985

4

Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.

Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. Nat Immunol. 2002 Jan;3(1):83-90. doi: 10.1038/ni746. Epub 2001 Dec 17. Nat Immunol. 2002. PMID: 11743585

5

A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.

Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. J Immunol. 2002 May 1;168(9):4472-9. doi: 10.4049/jimmunol.168.9.4472. J Immunol. 2002. PMID: 11970991

6

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.

Seki N, Hayakawa Y, Brooks AD, Wine J, Wiltrout RH, Yagita H, Tanner JE, Smyth MJ, Sayers TJ. Seki N, et al. Among authors: smyth mj. Cancer Res. 2003 Jan 1;63(1):207-13. Cancer Res. 2003. PMID: 12517799

7

Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.

Stewart TJ, Smyth MJ, Fernando GJ, Frazer IH, Leggatt GR. Stewart TJ, et al. Among authors: smyth mj. Cancer Res. 2003 Jun 15;63(12):3058-60. Cancer Res. 2003. PMID: 12810627

8

Differential antitumor immunity mediated by NKT cell subsets in vivo.

Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, Hayakawa Y, Godfrey DI, Smyth MJ. Crowe NY, et al. Among authors: smyth mj. J Exp Med. 2005 Nov 7;202(9):1279-88. doi: 10.1084/jem.20050953. J Exp Med. 2005. PMID: 16275765 Free PMC article.

9

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.

Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y. Smyth MJ, et al. J Immunol. 2006 Feb 1;176(3):1582-7. doi: 10.4049/jimmunol.176.3.1582. J Immunol. 2006. PMID: 16424187

10

Innate immune recognition and suppression of tumors.

Hayakawa Y, Smyth MJ. Hayakawa Y, et al. Among authors: smyth mj. Adv Cancer Res. 2006;95:293-322. doi: 10.1016/S0065-230X(06)95008-8. Adv Cancer Res. 2006. PMID: 16860661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters